Protection against Chikungunya virus induced arthralgia following prophylactic treatment with adenovirus vectored interferon (mDEF201)
- 14 May 2014
- journal article
- Published by Elsevier in Antiviral Research
- Vol. 108, 1-9
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Viruses Acquired AbroadDeutsches Ärzteblatt international, 2012
- Chikungunya Disease: Infection-Associated Markers from the Acute to the Chronic Phase of Arbovirus-Induced ArthralgiaPLOS Neglected Tropical Diseases, 2012
- Impaired quality of life after chikungunya virus infection: a 2-year follow-up studyRheumatology, 2012
- [Physiopathology of chronic arthritis following chikungunya infection in man].2012
- A 4-trifluoromethyl analogue of celecoxib inhibits arthritis by suppressing innate immune cell activationArthritis Research & Therapy, 2012
- High concentrations of circulating interleukin‐6 and monocyte chemotactic protein‐1 with low concentrations of interleukin‐8 were associated with severe chikungunya fever during the 2009–2010 outbreak in ThailandMicrobiology and Immunology, 2011
- Treatment of Yellow Fever Virus with an Adenovirus-Vectored Interferon, DEF201, in a Hamster ModelAntimicrobial Agents and Chemotherapy, 2011
- Probing the attenuation and protective efficacy of a candidate chikungunya virus vaccine in mice with compromised interferon (IFN) signalingVaccine, 2011
- A complex adenovirus vaccine against chikungunya virus provides complete protection against viraemia and arthritisVaccine, 2011
- Comparative Pathogenesis of Epidemic and Enzootic Chikungunya Viruses in a Pregnant Rhesus Macaque ModelThe American Journal of Tropical Medicine and Hygiene, 2010